Summit Financial’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $74.3K | Buy |
74,785
+9,591
| +15% | +$9.53K | ﹤0.01% | 807 |
|
|
2025
Q1 | $93.9K | Buy |
65,194
+18,666
| +40% | +$26.9K | ﹤0.01% | 703 |
|
|
2024
Q4 | $102K | Buy |
46,528
+7,150
| +18% | +$15.7K | ﹤0.01% | 630 |
|
|
2024
Q3 | $65K | Buy |
39,378
+6,691
| +20% | +$11K | ﹤0.01% | 539 |
|
|
2024
Q2 | $72.6K | Buy |
32,687
+6,823
| +26% | +$15.1K | ﹤0.01% | 487 |
|
|
2024
Q1 | $69.3K | Buy |
25,864
+10,355
| +67% | +$27.8K | ﹤0.01% | 381 |
|
|
2023
Q4 | $46.4K | Buy |
15,509
+3,622
| +30% | +$10.8K | ﹤0.01% | 350 |
|
|
2023
Q3 | $11.6K | Buy |
+11,887
| New | +$11.6K | ﹤0.01% | 330 |
|